GCS Research in the News

2014 Research News

February

Kathleen Lambert, M.D. Joins Research Team at Georgia Cancer Specialists, affiliated with Northside Hospital, in Decatur

January

GCS’ Mansoor Saleh among researchers of new drug for Pancreatic Cancer patients

Georgia Cancer Specialists, affiliated with the Northside Hospital Cancer Institute, Launches Clinical Research Program at Cumming Office

2013 Research News

April

Study Conducted by Georgia Cancer Specialist’s Dr. Mansoor Saleh Makes Medical News Headlines

February

Georgia Cancer Specialists Plays Key Role in Approval of Revolutionary ‘Smart Bomb’ Breast Cancer Drug

2012 Research News

December

GCS Physician Dr. Rodolfo Bordoni Featured in Local News Story on Lung Cancer Research

June

GCS Physician Talks to Local News about Breakthrough Breast Cancer Drug

Clinical Trials at Georgia Cancer Specialists Make National News At Annual Clinical Oncology Conference

April

Georgia Cancer Specialists Currently Enrolling Patients in Two Breast Cancer Clinical Trials

January

Dr. Jones Discusses Clinical Research in Middle Georgia on 41NBC

2011 Research News

November

GCS Research Patient Receives Generous Gift from Local School

October

Georgia Cancer Specialists Physician Contributing Author in Groundbreaking Clinical Trial

September

Georgia Cancer Specialists a Leader in Prostate Cancer Treatment, Research

August

GCS Physician Dr. Richard Loyd Recently Featured in The Athens Banner-Herald

Georgia Cancer Specialists Plays Major Role in Groundbreaking Clinical Trial

Georgia Cancer Specialists Expands Research Program to Athens

July

GCS Physicians Dr. Rodolfo Bordoni and Dr. Mansoor Saleh Presented at the 14th World Conference on Lung Cancer in Amsterdam

Georgia Cancer Specialists Macon Office Celebrates More Than 10 Years of Working With UAB Comprehensive Cancer Center to Bring Leading-edge Cancer Care to Central Georgia

June

Dr. Mansoor Saleh and GCS Research Team Contribute to New England Journal of Medicine Article

March

GCS Patient Achieves Wonderful Results Through Clinical Research

February

Research Patient Drives from Iowa to Thank Staff at Georgia Cancer Specialists

New Lymph Node Study Proves Less Can be More in Breast Cancer Care

Georgia Cancer Specialists Offers New Clinical Trial of Crizotinib for Lung Cancer Patients

GCS Clinical Research Coordinator Candice Griffith, R.N., Featured in Pulse magazine

2010 Research News

June

Georgia Cancer Specialists Testing Novel Oral Lung Cancer Drug Aimed at Non-smokers With Lung Cancer Who Have Specific Genetic Mutation

April

Drs. Bruce Feinberg and Mansoor Saleh Featured on WSB-AM's "Perspectives" Program

2009 Research News

May

Georgia Cancer Specialists Enrolls First Patient in the World in Novel Prostate Cancer Trial

March

New England Journal of Medicine Publishes Results of Two Prostate Screening Trials

Georgia Cancer Specialists is a national leader in advanced cancer treatment and research. GCS’s 44 physicians provide care in 26 Northside Hospital Cancer Institute locations across Metro Atlanta, North and Central Georgia. GCS is The Cancer Answer®.

THE CONTENT ON THE GCS WEB SITE IS NOT INTENDED IN ANY WAY TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH PROVIDER WITH ANY QUESTIONS YOU MAY HAVE REGARDING A MEDICAL CONDITION. NEITHER THE CONTENT NOR ANY OTHER PRODUCT OR SERVICE OFFERED BY OR THROUGH THE SITE IS INTENDED TO BE RELIED UPON FOR MEDICAL DIAGNOSIS OR TREATMENT. NEVER DISREGARD MEDICAL ADVICE OR DELAY IN SEEKING IT BECAUSE OF SOMETHING YOU HAVE READ ON THIS SITE! IN AN EMERGENCY CALL 911 OR YOUR LOCAL EMERGENCY ASSISTANCE NUMBER. NEITHER THE SITE NOR ANY OF ITS OWNERS, STAFF, OR AGENTS MAKE ANY REPRESENTATION OR WARRANTY WITH RESPECT TO THE CONTENT OF THE SITE OR INFORMATION FURNISHED BY IT OR ANY AGENTS, EMPLOYEES OR REPRESENTATIVES AND SPECIFICALLY DISCLAIM TO THE FULLEST EXTENT PERMITTED BY LAW ANY AND ALL WARRANTIES, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY, COMPLETENESS, TIMELINESS, CORRECTNESS, NONINFRINGEMENT, AND FITNESS FOR ANY PARTICULAR USE, APPLICATION, OR PURPOSE.